Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted mean survival difference

Carolien C.H.M. Maas, David M. Kent, Avinash G. Dinmohamed, David van Klaveren
doi: https://doi.org/10.1101/2024.12.19.24319347

Article Information

doi 
https://doi.org/10.1101/2024.12.19.24319347
History 
  • December 22, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Carolien C.H.M. Maas1,2,3,*,
  2. David M. Kent3,
  3. Avinash G. Dinmohamed1,2 and
  4. David van Klaveren1,3
  1. 1Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands
  2. 2Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands
  3. 3Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, USA
  1. ↵*Corresponding author
    Carolien C.H.M. Maas, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, Netherlands, c.h.m.maas{at}erasmusmc.nl
Back to top
Posted December 22, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted mean survival difference
Carolien C.H.M. Maas, David M. Kent, Avinash G. Dinmohamed, David van Klaveren
medRxiv 2024.12.19.24319347; doi: https://doi.org/10.1101/2024.12.19.24319347
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area